Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

We describe a new class of NO-donor hypoglycemic products obtained by joining tolbutamide, a typical hypoglycemic sulfonylurea, with a NO-donor moiety through a hard link. As NO-donors we chose either furoxan (1,2,5-oxadiazole 2-oxide) derivatives or the classical nitrooxy function. A preliminary biological characterization of these compounds, including stimulation of insulin release from cultured rat pancreatic β-cells and in vitro vasodilator and anti-aggregatory activities, is reported. Copyright © 2012 Elsevier Ltd. All rights reserved.

Citation

Yasinalli Tamboli, Loretta Lazzarato, Elisabetta Marini, Stefano Guglielmo, Michela Novelli, Pascale Beffy, Pellegrino Masiello, Roberta Fruttero, Alberto Gasco. Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. Bioorganic & medicinal chemistry letters. 2012 Jun 1;22(11):3810-5

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22565215

View Full Text